Haemonetics (HAE) Non-Current Assets (2010 - 2026)

Haemonetics has reported Non-Current Assets for 17 years, with the latest figure at $1.6 billion in Q2 2026.

• On a quarterly basis, Non-Current Assets changed 0.36% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 0.74% increase from a year earlier, with the FY2026 full-year figure at $1.6 billion, up 2.97% from the prior year.
• Non-Current Assets was $1.6 billion for Q2 2026 at Haemonetics, roughly flat from $1.6 billion in the prior quarter.
• The five-year high for Non-Current Assets was $1.6 billion in Q3 2024, with the low at $1.1 billion in Q1 2022.
• Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
• The largest YoY upside for Non-Current Assets was 69.6% in 2022 against a maximum downside of 2.01% in 2022.
• Over 5 years, Non-Current Assets stood at $1.2 billion in 2022, then climbed by 22.5% to $1.4 billion in 2023, then rose by 6.27% to $1.5 billion in 2024, then rose by 1.43% to $1.5 billion in 2025, then climbed by 0.48% to $1.6 billion in 2026.
• The last three Non-Current Assets figures came in at $1.6 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.